NEW YORK, March 7, 2012 (GLOBE NEWSWIRE) -- Synergy Pharmaceuticals, Inc. (Nasdaq:SGYP) (Nasdaq:SGYPU) (Nasdaq:SGYPW), a developer of new drugs to treat gastrointestinal disorders and diseases, today announced that its President and CEO, Gary S. Jacob, Ph.D, will present at the ROTH 24th Annual Growth Stock Conference on Tuesday, March 13, 2012 at 5:00 p.m. PDT at the Ritz Carlton in Dana Point, CA.
